25 participants
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-11-19
- Start Date:
- 2021-11-10
- Completion:
- 2023-09-30
Conditions
- Esophageal Neoplasm
- Immunotherapy
- Radiotherapy
Interventions
- DRUG
No Results Yet